H.Res. 248House110th Congress (2007-2009)In Committee

Honoring the contributions of patient participants in clinical trials.

Introduced March 15, 2007

Legislative Activity

Stay on top of the latest movement without scrolling through every action

2 earlier actions
HouseCommittee Latest Action

Referred to the Subcommittee on Health.

March 16, 2007

View full timeline
HouseIntro Referral

Introduced in House

March 15, 2007

HouseIntro Referral

Referred to the House Committee on Energy and Commerce.

March 15, 2007

HouseCommittee

Referred to the Subcommittee on Health.

March 16, 2007

Floor Debate

5 members

What members said about H.Res. 248 on the floor

4 Republicans1 Democrat
Dennis A. Cardoza
Rep. Dennis A. CardozaD-CA-18 · Jul 10, 2008

Madam Speaker, by direction of the Committee on Rules, I call up House Resolution 1317 and ask for its immediate consideration. Madam Speaker, for the purpose of debate only, I yield the customary 30…

Doc Hastings
Rep. Doc HastingsR-WA-4 · Jul 10, 2008

Madam Speaker, I want to thank my good friend from California (Mr. Cardoza) for yielding me the customary 30 minutes, and I yield myself as much time as I may consume. (Mr. HASTINGS of Washington…

Daniel E. Lungren
Rep. Daniel E. LungrenR-CA-3 · Jul 10, 2008

I appreciate the gentleman allowing me to get in the midst of this intramural squabble here on the Rules Committee. It seems like it was just the night before last that we came back to work…

Rob Bishop
Rep. Rob BishopR-UT-1 · Jul 10, 2008

Madam Speaker, I thank the gentleman from Washington for yielding. Bill Veeck was an old baseball owner and entrepreneur who used to say, ``I don't ever break the rules, I just test their…

Lee Terry
Rep. Lee TerryR-NE-2 · Jul 10, 2008

Thank you. I appreciate this opportunity. My friend from California, I'd like to clarify a little bit. The 66 million acres are land that hasn't been authorized by Congress. In fact, the efforts by…

Bill Text

Latest available legislative text

Reading Mode
Latest
Introduced in HouseIssued March 15, 2007

IV

110th CONGRESS

1st Session

H. RES. 248

IN THE HOUSE OF REPRESENTATIVES

March 15, 2007

Mr. Boucher (for himself and Mr. Cannon) submitted the following resolution; which was referred to the Committee on Energy and Commerce

RESOLUTION

Honoring the contributions of patient participants in clinical trials.

Whereas clinical trials of new medicines and vaccines are vital to advancing science and conquering disease;

Whereas a clinical trial is a scientific test of the effectiveness and safety of a new medicine or vaccine with the consent of human volunteers, providing invaluable information to medical researchers and physicians;

Whereas over 2,300,000 people enable medical advances by actively participating in nearly 80,000 clinical trials every year in the United States;

Whereas participants join clinical trials in order to help find better ways to prevent, detect, diagnose, or treat illnesses and to improve medicines;

Whereas every patient using a medicine greatly benefits from essential knowledge of safety and effectiveness possible only through the contribution of clinical trial volunteers;

Whereas clinical trial volunteers are credited with helping to develop the treatments that have cut the death rate of heart disease by 50 percent;

Whereas 20 percent of all participants in trials of new medicines are over the age of 65, creating invaluable knowledge about the unique needs of seniors;

Whereas over 60 percent of children with cancer are enrolled in clinical trials, offering hope to children and their families across America;

Whereas 41 percent of eligible AIDS patients participate in cooperative studies, enabling continued progress in the effort to defeat this disease;

Whereas 80 percent of all eligible lung cancer patients are enrolled in a clinical trial, allowing new generations of medicines to advance against a disease that has not previously had effective treatments;

Whereas the contributions of clinical trial participants have led to the discovery of new treatments and cures and an improved quality of life for all; and

Whereas clinical trial volunteers are needed now more than ever to enable advances against conditions like Alzheimer’s, which will exact an incalculable human and economic cost as baby boomers become seniors unless effective and safe new treatments are developed: Now, therefore, be it

That the House of Representatives—

(1)

honors and recognizes the sacrifice, commitment, and contributions of clinical trial participants; and

(2)

encourages everyone to learn about the importance of clinical trials and the important role of trial participants.